Pulmonx (LUNG) Equity Average (2019 - 2025)

Pulmonx (LUNG) has 7 years of Equity Average data on file, last reported at $57.1 million in Q4 2025.

• Equity Average for Q4 2025 came in at $57.1 million, down 36.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $57.1 million (down 36.49% YoY), and the FY2025 annual result was $70.0 million, down 31.45% from the prior year.
• Equity Average declined to $57.1 million in Q4 2025 per LUNG's latest filing, from $64.6 million in the prior quarter.
• Over five years, Equity Average peaked at $221.1 million in Q1 2021 and troughed at $57.1 million in Q4 2025.
• A 5-year average of $137.7 million and a median of $134.4 million in 2023 frame the typical range for Equity Average.
• The sharpest annual moves came in 2021 and 2025: Equity Average surged 1958.03% in 2021, then tumbled 36.49% in 2025.
• A 5-year view of Equity Average shows it stood at $198.0 million in 2021, then dropped by 19.84% to $158.7 million in 2022, then slipped by 23.13% to $122.0 million in 2023, then slipped by 26.36% to $89.9 million in 2024, then plunged by 36.49% to $57.1 million in 2025.
• Business Quant data shows LUNG's Equity Average at $57.1 million in Q4 2025, $64.6 million in Q3 2025, and $73.4 million in Q2 2025.